Grant funding, Potenzone, Protometrix and Affomix, Harvard's stem cell duo, and Haussler | GenomeWeb

Here's something that will make you long for the good old days: five years ago, getting grant funding seemed like a major challenge. In our May 2004 issue of Genome Technology — just after then-NIH Director Elias Zerhouni had succeeded in doubling the agency's budget — we devoted our cover story to offering advice on writing and winning grants, and we profiled a number of program directors who could offer their assistance to readers.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.